Clinical trial
N-Acetylcysteine in Neonatal Congenital Heart Surgery (INACT Study)
NCT00374088 · University of Michigan, Other · Completed
Key facts
| NCT number | NCT00374088 |
|---|---|
| Title | N-Acetylcysteine in Neonatal Congenital Heart Surgery (INACT Study) |
| Official title | Attenuation of Myocardial Dysfunction by N-Acetylcysteine in Infants Undergoing Arterial Switch Procedure |
| Lead sponsor | University of Michigan, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Transposition of Great Vessels, Congenital Heart Disease |
| Intervention type | Drug |
| Interventions | N-acetylcysteine, Placebo |
| Enrollment | 21 |
| Start date | Feb 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Sep 8, 2006 |
| Last update posted | Jan 19, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: